professionals are saying

Tell us about your project

Be contacted

MEDIA

CDMO and Radiopharmaceuticals Lemer Pax
11 August 2026

CDMO and Radiopharmaceuticals: What is a production line and How is it equipped?

The production of radiopharmaceuticals is experiencing unprecedented growth, driven by the rise of nuclear medicine and the arrival of major new pharmaceutical players. To meet this demand, new CDMO (Contract Development and Manufacturing Organization) lines dedicated to radio-medicine are emerging....
Media_Room_CP_IRE selects Lemer Pax to equip its new radiopharmaceutical CDMO facility in Fleurus
13 January 2026

IRE selects Lemer Pax to equip its new radiopharmaceutical CDMO facility in Fleurus

Fleurus, Belgium – January 13, 2026 IRE (The National Institute for Radioelements) has selected Lemer Pax, a French expert in radiation protection solutions, to supply the shielded hot cells for its new radiopharmaceutical CDMO (Contract Development and Manufacturing Organisation) facility...
The Lifecycle of Radiopharmaceuticals: From Research to Clinical Use

The Lifecycle of Radiopharmaceuticals: From Research to Clinical Use

Radiopharmaceuticals are drugs that contain radionuclides.

They are primarily used for two main purposes: diagnostic procedures and treatment assessments through imaging. The radiation detected by nuclear medicine cameras helps doctors observe and analyse how the human body functions.

Additionally, they serve therapeutic purposes, as the emitted radiation can specifically target cancerous or diseased cells. Although therapeutic use currently represents only about 10% of radiopharmaceutical applications, this practice is rapidly expanding.

France © 2026 - Lemer Pax